Cardiovascular prevention in general practice: Development and validation of an algorithm

Acta Cardiologica

Volumn 59, Issue 6, 2004, Pages 598-605

  Boland, Benoit ^a   De Muylder, Régis ^a   Goderis, Geert ^a   Degryse, Jan ^b   Gueuning, Yves ^c   Paulus, Dominique ^a   Jeanjean, Michel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Sci Society of General Practice   (Belgium)

Author keywords

Algorithm; Cardiovascular prevention; Case finding; General practice

Indexed keywords

ADULT; AGED; ALGORITHM; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GENERAL PRACTICE; GENERAL PRACTITIONER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PHYSICIAN; PREDICTION; PROPHYLAXIS; RANDOMIZATION; REPRODUCIBILITY; RISK ASSESSMENT; SCREENING; SMOKING; VALIDATION PROCESS;

ADULT; AGED; ALGORITHMS; CARDIOVASCULAR DISEASES; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 10244236544     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.59.6.2005241     Document Type: Article

References (29)

1. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-7.
2. De Henauw S, De Bacquer D, de Smet P, Kornitzer M, De Backer G. Trends in coronary heart disease in two Belgian areas: results from the MONICA Ghent-Charleroi study. J Epidemiol Community Health 1999; 53: 89-98.
3. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-10.
4. McManus RJ, Mant J, Meulendijks CF, Salter RA, Pattison HM, Roalfe AK, Hobbs FD. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: a cross-sectional study. BMJ 2002; 324: 459-64.
5. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P for the WHO MONICA Project. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547-57.
6. Euroaspire II group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from Euroaspire II. Eur Heart J 2001; 22: 554-72.
7. De Muylder R, Lorant V, Paulus D, Nackers F, Jeanjean M, Boland B. Obstacles to cardiovascular prevention in general practice. Acta Cardiol 2004; 59: 119-25.
8. Robson J, Boomla K, Hart B, Feder G. Estimating cardiovascular risk for primary prevention: outstanding question for primary care. BMJ 2000; 320: 702-4.
9. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83.
10. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular risk profiles. Am Heart J 1991; 121: 293-8.
11. WHO MONICA Project principal investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
12. Assmann G, Schulte H. Indentification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110: S11-21.
13. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1-S29.
14. Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 2001; 85: 37-43.
15. nd ed. New York: John Wiley and Sons, 1981.
16. Brohet C, Janssens D, Beck D, Hannut R, Kulbertus H, Lavenne F, Lefebvre P, Rorive G. Cardiovascular risk factors in a sample of a rural Belgian population: the Bellux MONICA study. Acta Med Scand 1998; Suppl 728: 129-36.
17. De Henauw S, De Backer G. Coronair lijden in België (coronary heart disease in Belgium). Tijdschrift voor Geneeskunde 1995; 51: 1607-16.
18. West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention study: identification of highrisk groups and comparison with other cardiovascular intervention trials. Lancet 1996; 348: 1339-42.
19. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267-70.
20. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med 1988; 319: 1365-9.
21. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
22. Blair SN, Kohl HW, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093-8.
23. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
24. Heart Protection Study Collaborative Group. MCR/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
25. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on CV events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med 2000; 342: 145-53.
26. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
27. Sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
28. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
29. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499-504.